Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Here’s Why

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped down before the market opened on Wednesday . The stock had previously closed at $9.72, but opened at $9.24. Sysmex shares last traded at $9.62, with a volume of 44,221 shares trading hands.

Analyst Upgrades and Downgrades

SSMXY has been the topic of several research reports. The Goldman Sachs Group upgraded Sysmex from a “hold” rating to a “buy” rating in a report on Thursday, October 9th. Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a report on Thursday, August 14th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy”.

Sysmex Stock Performance

The company has a market capitalization of $6.05 billion, a price-to-earnings ratio of 19.21 and a beta of 1.16. The stock has a 50 day moving average of $11.77 and a 200 day moving average of $14.51. The company has a quick ratio of 2.49, a current ratio of 3.37 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. Sysmex had a net margin of 9.35% and a return on equity of 10.20%. The firm had revenue of $826.60 million for the quarter, compared to the consensus estimate of $880.80 million. As a group, analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.